The Utility of Thiopurine Methyltransferase Enzyme Testing in Inflammatory Bowel Disease
OBJECTIVE: To assess the levels of red blood cell thiopurine methyltransferase (TPMT) in subjects with inflammatory bowel disease (IBD) and to determine how these levels impacted thiopurine dosing and leukopenia over the first six months of therapy.
Saved in:
Main Authors: | Laura Chisick, Curtis Oleschuk, Charles N Bernstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2013/280860 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update of Immunomodulatory Therapy for Inflammatory Bowel Disease
by: Charles N Bernstein
Published: (1994-01-01) -
The Utility of Fecal Calprotectin in the Real-World Clinical Care of Patients with Inflammatory Bowel Disease
by: Esmail Abej, et al.
Published: (2016-01-01) -
Immunosuppressive and Immunomodulatory Therapy for Inflammatory Bowel Disease
by: Charles N Bernstein, et al.
Published: (1993-01-01) -
Personalization of thiopurine therapy: Current recommendations and future perspectives
by: Urbančič Dunja, et al.
Published: (2024-09-01) -
Characterization of Inflammatory Bowel Disease in Elderly Patients: A Review of Epidemiology, Current Practices and Outcomes of Current Management Strategies
by: Peter Stepaniuk, et al.
Published: (2015-01-01)